|
1
|
Warmuth C, Gunther M and Zimmer C:
Quantification of blood flow in brain tumors: Comparison of
arterial spin labeling and dynamic susceptibility-weighted
contrast-enhanced MR imaging. Radiology. 228:523–532. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hakyemez B, Erdogan C, Ercan I, Ergin N,
Uysal S and Atahan S: High-grade and low-grade gliomas:
Differentiation by using perfusion MR imaging. Clin Radiol.
60:493–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hirai T, Murakami R, Nakamura H, Kitajima
M, Fukuoka H, Sasao A, Akter M, Hayashida Y, Toya R, Oya N, et al:
Prognostic value of perfusion MR imaging of high-grade
astrocytomas: Long-term follow-up study. AJNR Am J Neuroradiol.
29:1505–1510. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bulakbasi N, Kocaoglu M, Farzaliyev A,
Tayfun C, Ucoz T and Somuncu I: Assessment of diagnostic accuracy
of perfusion MR imaging in primary and metastatic solitary
malignant brain tumors. AJNR Am J Neuroradiol. 26:2187–2199.
2005.PubMed/NCBI
|
|
6
|
Sadeghi N, D'Haene N, Decaestecker C,
Levivier M, Metens T, Maris C, Wikler D, Baleriaux D, Salmon I and
Goldman S: Apparent diffusion coefficient and cerebral blood volume
in brain gliomas: Relation to tumor cell density and tumor
microvessel density based on stereotactic biopsies. AJNR Am J
Neuroradiol. 29:476–482. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prager AJ, Martinez N, Beal K, Omuro A,
Zhang Z and Young RJ: Diffusion and perfusion MRI to differentiate
treatment-related changes including pseudoprogression from
recurrent tumors in high-grade gliomas with histopathologic
evidence. AJNR Am J Neuroradiol. 36:877–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao HF, Chen ZY, Lou X, Wang YL, Gui QP,
Wang Y, Shi KN, Zhou ZY, Zheng DD, Wang DJ and Ma L: Astrocytic
tumour grading: A comparative study of three-dimensional
pseudocontinuous arterial spin labelling, dynamic susceptibility
contrast-enhanced perfusion-weighted imaging, and
diffusion-weighted imaging. Eur Radiol. 25:3423–3430. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leu K, Enzmann DR, Woodworth DC, Harris
RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF and
Ellingson BM: Hypervascular tumor volume estimated by comparison to
a large-scale cerebral blood volume radiographic atlas predicts
survival in recurrent glioblastoma treated with bevacizumab. Cancer
Imaging. 14:312014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Bihan D: Apparent diffusion coefficient
and beyond: What diffusion MR imaging can tell us about tissue
structure. Radiology. 268:318–322. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elobeid A, Bongcam-Rudloff E, Westermark B
and Nister M: Effects of inducible glial fibrillary acidic protein
on glioma cell motility and proliferation. J Neurosci Res.
60:245–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faria MH, Goncalves BP, do Patrocinio RM,
de Moraes-Filho MO and Rabenhorst SH: Expression of Ki-67,
topoisomerase IIalpha and c-MYC in astrocytic tumors: Correlation
with the histopathological grade and proliferative status.
26:519–527. 2006.PubMed/NCBI
|
|
13
|
Christmann M, Nagel G, Horn S, Krahn U,
Wiewrodt D, Sommer C and Kaina B: MGMT activity, promoter
methylation and immunohistochemistry of pretreatment and recurrent
malignant gliomas: A comparative study on astrocytoma and
glioblastoma. Int J Cancer. 127:2106–2118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwee TC, Galbán CJ, Tsien C, Junck L,
Sundgren PC, Ivancevic MK, Johnson TD, Meyer CR, Rehemtulla A, Ross
BD and Chenevert TL: Comparison of apparent diffusion coefficients
and distributed diffusion coefficients in high-grade gliomas. J
Magn Reson Imaging. 31:531–537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee EJ, Lee SK, Agid R, Bae JM, Keller A
and Terbrugge K: Preoperative grading of presumptive low-grade
astrocytomas on MR imaging: Diagnostic value of minimum apparent
diffusion coefficient. AJNR Am J Neuroradiol. 29:1872–1877. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kono K, Inoue Y, Nakayama K, Shakudo M,
Morino M, Ohata K, Wakasa K and Yamada R: The role of
diffusion-weighted imaging in patients with brain tumors. AJNR Am J
Neuroradiol. 22:1081–1088. 2001.PubMed/NCBI
|
|
17
|
Yamasaki F, Kurisu K, Satoh K, Arita K,
Sugiyama K, Ohtaki M, Takaba J, Tominaga A, Hanaya R, Yoshioka H,
et al: Apparent diffusion coefficient of human brain tumors at MR
imaging. Radiology. 235:985–991. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Calli C, Kitis O, Yunten N, Yurtseven T,
Islekel S and Akalin T: Perfusion and diffusion MR imaging in
enhancing malignant cerebral tumors. Eur J Radiol. 58:394–403.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stadnik TW, Chaskis C, Michotte A, Shabana
WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V and Osteaux M:
Diffusion-weighted MR imaging of intracerebral masses: Comparison
with conventional MR imaging and histologic findings. AJNR Am J
Neuroradiol. 22:969–976. 2001.PubMed/NCBI
|
|
20
|
Ueda M, Terai Y, Kumagai K, Ueki K,
Yamaguchi H, Akise D and Ueki M: Vascular endothelial growth factor
C gene expression is closely related to invasion phenotype in
gynecological tumor cells. Gynencol Oncol. 82:162–166. 2001.
View Article : Google Scholar
|
|
21
|
Kim HS and Kim SY: A prospective study on
the added value of pulsed arterial spin-labeling and apparent
diffusion coefficients in the grading of gliomas. AJNR Am J
Neuroradiol. 28:1693–1699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hilario A, Ramos A, Perez-Nuñez A,
Salvador E, Millan JM, Lagares A, Sepulveda JM, Gonzalez-Leon P,
Hernandez-Lain A and Ricoy JR: The added value of apparent
diffusion coefficient to cerebral blood volume in the preoperative
grading of diffuse gliomas. AJNR Am J Neuroradiol. 33:701–707.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer
A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C,
et al: Exploratory investigation of eight circulating plasma
markers in brain tumor patients. Neurosurg Rev. 36:45–56. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kimura F, Okayasu I, Kakinuma H, Satoh Y,
Kuwao S, Saegusa M and Watanabe J: Differential diagnosis of
reactive mesothelial cells and malignant mesothelioma cells using
the cell proliferation markers minichromosome maintenance protein
7, geminin, topoisomerase II alpha and Ki-67. Acta Cytol.
57:384–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maia AC Jr, Malheiros SM, da Rocha AJ, da
Silva CJ, Gabbai AA, Ferraz FA and Stávale JN: MR cerebral blood
volume maps correlated with vascular endothelial growth factor
expression and tumor grade in nonenhancing gliomas. AJNR Am J
Neuroradiol. 26:777–783. 2005.PubMed/NCBI
|
|
26
|
Felsberg J, Thon N, Eigenbrod S, Hentschel
B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Löffler
M, et al: Promoter methylation and expression of MGMT and
the DNA mismatch repair genes MLH1, MSH2, MSH6 and
PMS2 in paired primary and recurrent glioblastomas. Int J
Cancer. 129:659–670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Svolos P, Kousi E, Kapsalaki E, Theodorou
K, Fezoulidis I, Kappas C and Tsougos I: The role of diffusion and
perfusion weighted imaging in the differential diagnosis of
cerebral tumors: A review and future perspectives. Cancer Imaging.
14:202014.PubMed/NCBI
|
